SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Abroad (travel likely)RecruitingPHASE3

Conditions

Colorectal Cancer · Liver Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Jun Hu) · zslyllb@mail.sysu.edu.cn · +86-020-38379764

Study leads

Jun Huang, PhD.
Principal Investigator
Sun Yat-sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

Colorectal Cancer Metastatic · Liver Metastases · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

New York, United States

Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

Colorectal Cancer · Liver Metastases · Genetic Change

Abroad (travel likely)Recruiting

Barcelona, Spain

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Rectal Cancer · Total Neoadjuvant Therapy · Radiotherapy

Abroad (travel likely)RecruitingPHASE3

Wuhan, China

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Rectal Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Changchun, China